(Q43102151)

English

Regulatory (FoxP3+) T-cell tumor infiltration is a favorable prognostic factor in advanced colon cancer patients undergoing chemo or chemoimmunotherapy

scientific article published in May 2010

In more languages

default for all languages

No label defined

No description defined

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

13 November 2017

Regulatory (FoxP3+) T-cell tumor infiltration is a favorable prognostic factor in advanced colon cancer patients undergoing chemo or chemoimmunotherapy (English)

1 reference

Europe PubMed Central

PubMed publication ID

13 November 2017

1 reference

based on heuristic

inferred from title

Pierpaolo Correale

1

1 reference

Europe PubMed Central

PubMed publication ID

13 November 2017

Pierfrancesco Tassone

11

object named as

Pierfrancesco Tassone

1 reference

Europe PubMed Central

PubMed publication ID

13 November 2017

Pierosandro Tagliaferri

13

object named as

Pierosandro Tagliaferri

1 reference

Europe PubMed Central

PubMed publication ID

13 November 2017

author name string

Maria Saveria Rotundo

2

1 reference

Europe PubMed Central

PubMed publication ID

13 November 2017

Maria Teresa Del Vecchio

3

1 reference

Europe PubMed Central

PubMed publication ID

13 November 2017

Cinzia Remondo

4

1 reference

Europe PubMed Central

PubMed publication ID

13 November 2017

Cristina Migali

5

1 reference

Europe PubMed Central

PubMed publication ID

13 November 2017

Chiara Ginanneschi

6

1 reference

Europe PubMed Central

PubMed publication ID

13 November 2017

Kwong Y Tsang

7

1 reference

Europe PubMed Central

PubMed publication ID

13 November 2017

Antonella Licchetta

8

1 reference

Europe PubMed Central

PubMed publication ID

13 November 2017

Susanna Mannucci

9

1 reference

Europe PubMed Central

PubMed publication ID

13 November 2017

Lucia Loiacono

10

1 reference

Europe PubMed Central

PubMed publication ID

13 November 2017

Guido Francini

12

1 reference

Europe PubMed Central

PubMed publication ID

13 November 2017

publication date

1 May 2010

1 reference

Europe PubMed Central

PubMed publication ID

13 November 2017

Journal of Immunotherapy

1 reference

Europe PubMed Central

PubMed publication ID

13 November 2017

33

1 reference

Europe PubMed Central

PubMed publication ID

13 November 2017

4

1 reference

Europe PubMed Central

PubMed publication ID

13 November 2017

435-441

1 reference

Europe PubMed Central

PubMed publication ID

13 November 2017

Central memory self/tumor-reactive CD8+ T cells confer superior antitumor immunity compared with effector memory T cells

1 reference

https://pubmed.ncbi.nlm.nih.gov/20386463

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Regulatory T cells in cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/20386463

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Intratumoral balance of regulatory and cytotoxic T cells is associated with prognosis of hepatocellular carcinoma after resection.

1 reference

https://pubmed.ncbi.nlm.nih.gov/20386463

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Autoimmunity correlates with tumor regression in patients with metastatic melanoma treated with anti-cytotoxic T-lymphocyte antigen-4.

1 reference

https://pubmed.ncbi.nlm.nih.gov/20386463

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Specific recruitment of regulatory T cells in ovarian carcinoma fosters immune privilege and predicts reduced survival

1 reference

https://pubmed.ncbi.nlm.nih.gov/20386463

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Provision of granulocyte-macrophage colony-stimulating factor converts an autoimmune response to a self-antigen into an antitumor response

1 reference

https://pubmed.ncbi.nlm.nih.gov/20386463

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

FOXP3 expression accurately defines the population of intratumoral regulatory T cells that selectively accumulate in metastatic melanoma lesions

1 reference

https://pubmed.ncbi.nlm.nih.gov/20386463

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Naturally arising CD25+CD4+ regulatory T cells in tumor immunity.

1 reference

https://pubmed.ncbi.nlm.nih.gov/20386463

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A novel biweekly multidrug regimen of gemcitabine, oxaliplatin, 5-fluorouracil (5-FU), and folinic acid (FA) in pretreated patients with advanced colorectal carcinoma

1 reference

https://pubmed.ncbi.nlm.nih.gov/20386463

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Analysis of FOXP3 protein expression in human CD4+CD25+ regulatory T cells at the single-cell level

1 reference

https://pubmed.ncbi.nlm.nih.gov/20386463

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

CD4+CD25+ regulatory T cells suppress tumor immunity but are sensitive to cyclophosphamide which allows immunotherapy of established tumors to be curative

1 reference

https://pubmed.ncbi.nlm.nih.gov/20386463

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Utility of tumour-infiltrating CD25+FOXP3+ regulatory T cell evaluation in predicting local recurrence in vertical growth phase cutaneous melanoma

1 reference

https://pubmed.ncbi.nlm.nih.gov/20386463

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Prognostic significance of autoimmunity during treatment of melanoma with interferon.

1 reference

https://pubmed.ncbi.nlm.nih.gov/20386463

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Recruitment of dendritic cells and enhanced antigen-specific immune reactivity in cancer patients treated with hr-GM-CSF (Molgramostim) and hr-IL-2. results from a phase Ib clinical trial.

1 reference

https://pubmed.ncbi.nlm.nih.gov/20386463

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Leucovorin and fluorouracil with or without oxaliplatin as first-line treatment in advanced colorectal cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/20386463

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The impact of CD4+CD25+ Treg on tumor specific CD8+ T cell cytotoxicity and cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/20386463

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Chemotherapeutic drugs may be used to enhance the killing efficacy of human tumor antigen peptide-specific CTLs

1 reference

https://pubmed.ncbi.nlm.nih.gov/20386463

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Tumor-Infiltrating FOXP3+ T Regulatory Cells Show Strong Prognostic Significance in Colorectal Cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/20386463

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Intraepithelial effector (CD3+)/regulatory (FoxP3+) T-cell ratio predicts a clinical outcome of human colon carcinoma

1 reference

https://pubmed.ncbi.nlm.nih.gov/20386463

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Quantification of Regulatory T Cells Enables the Identification of High-Risk Breast Cancer Patients and Those at Risk of Late Relapse

1 reference

https://pubmed.ncbi.nlm.nih.gov/20386463

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Cell-based cancer gene therapy: breaking tolerance or inducing autoimmunity?

1 reference

https://pubmed.ncbi.nlm.nih.gov/20386463

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Regulatory T cells, a potent immunoregulatory target for CAM researchers: the ultimate antagonist (I).

1 reference

https://pubmed.ncbi.nlm.nih.gov/20386463

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

FOXP3 expression and overall survival in breast cancer.

1 reference

https://pubmed.ncbi.nlm.nih.gov/20386463

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Immunity feedback and clinical outcome in colon cancer patients undergoing chemoimmunotherapy with gemcitabine + FOLFOX followed by subcutaneous granulocyte macrophage colony-stimulating factor and aldesleukin (GOLFIG-1 Trial).

1 reference

https://pubmed.ncbi.nlm.nih.gov/20386463

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Autoantigens: the critical partner in initiating and propagating systemic autoimmunity

1 reference

https://pubmed.ncbi.nlm.nih.gov/20386463

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Inhibition of CD4(+)25+ T regulatory cell function implicated in enhanced immune response by low-dose cyclophosphamide

1 reference

https://pubmed.ncbi.nlm.nih.gov/20386463

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Systemic therapy for colorectal cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/20386463

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

CD4+CD25+ T cells as key regulators of immune responses

1 reference

https://pubmed.ncbi.nlm.nih.gov/20386463

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Chemo-immunotherapy of metastatic colorectal carcinoma with gemcitabine plus FOLFOX 4 followed by subcutaneous granulocyte macrophage colony-stimulating factor and interleukin-2 induces strong immunologic and antitumor activity in metastatic colon c

1 reference

https://pubmed.ncbi.nlm.nih.gov/20386463

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

In vivo sites and cellular mechanisms of T reg cell-mediated suppression

1 reference

https://pubmed.ncbi.nlm.nih.gov/20386463

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The anticancer immune response: indispensable for therapeutic success?

1 reference

https://pubmed.ncbi.nlm.nih.gov/20386463

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1097/CJI.0B013E3181D32F01

1 reference

Europe PubMed Central

PubMed publication ID

13 November 2017

PMC publication ID

0 references

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

13 November 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q43102151&oldid=2032510236"